Oxidative stress may play a role in the pathogenesis of diabetes suggesting that antioxidants could delay or prevent diabetes (Ruhe & McDonald, 2001) . Vitamin E is an important fat-soluble antioxidant (Institute of Medicine, 2000) , and some evidence suggests that a low plasma concentration of this vitamin is associated with an increased risk for diabetes (Salonen et al. 1995; Reunanen et al. 1998; Mayer-Davis et al. 2002) . Furthermore, higher dietary intakes of a-tocopherol, g-tocopherol and b-tocotrienol have also been associated with a lower risk of developing diabetes (Montonen et al. 2004) . However, studies about the effects of vitamin E supplementation on concentrations of glucose, glycosylated haemoglobin and other glycated proteins, and insulin have produced inconsistent results. Furthermore, most of the previous research has examined the effects of a-tocopherol.
In recent years, an interest in the role of g-tocopherol in health and disease has emerged (Jiang et al. 2001; Devaraj & Traber, 2003) . g-Tocopherol differs structurally from atocopherol by having two instead of three methyl groups on the chromanol ring. Although the diet contains more g-tocopherol than a-tocopherol and intestinal absorption and secretion into chylomicrons is similar for these two principal forms of vitamin E, a-tocopherol occurs in far greater concentrations in blood because of the preferential resecretion of this compound from the liver (Traber, 1999) . However, the concentration of g-tocopherol in tissues may be considerably higher than its plasma concentrations (Burton et al. 1998 ). Because of differences in structure, activity and metabolism, the biological actions of aand g-tocopherol differ.
Because vitamin E may play a role in the pathogenesis of diabetes but little is known about any such role for g-tocopherol, we examined the cross-sectional associations between aand g-tocopherol and concentrations of glucose, glycosylated haemoglobin, insulin and C-peptide among US adults.
Methods
This cross-sectional analysis used data from the National Health and Nutrition Examination Survey obtained during (Centers for Disease Control and Prevention, 2002 . In this survey, a representative sample of the civilian, non-institutionalized US population was selected through a stratified multistage sampling design. There were four stages of selection: counties or small groups of contiguous counties, a block or group of blocks containing a cluster of households, households, and one or more participants from households. Because of the differential probabilities of selection, sampling weights were created that reflected the base probabilities of selection, adjustment for nonresponse and post-stratification. Trained interviewers, using a computer-assisted personal interview system, interviewed participants at home. Participants were asked to attend the mobile examination centre, where they were requested to complete additional questionnaires, undergo various examinations and provide a blood sample. The survey was approved by the human subjects office at the Centers for Disease Control and Prevention and was conducted according to the principles of the Declaration of Helsinki. All participants signed an informed consent.
Plasma glucose concentration was measured at the University of Missouri using the hexokinase method on a Cobas Mira Chemistry System (Roche Diagnostic Systems, Inc., Montclair, NJ, USA We included the following covariates: age, sex, race or ethnicity (white, African American, Mexican American, other), education (, high school, high school diploma or general equivalency diploma, . high school), smoking status, total cholesterol concentration and triacylglycerol concentrations, systolic blood pressure, waist circumference, alcohol use, physical activity, time watching television or video viewing or using a computer, and use of vitamin/mineral/dietary supplements. Three categories of smoking status (current, former, never) were created from the questions 'Have you smoked at least 100 cigarettes in your entire life?' and 'Do you now smoke cigarettes?' Serum cholesterol and triacylglycerol concentrations were measured enzymatically on a Hitachi 717 Analyzer (Boehringer Mannheim Diagnostics, Indianapolis, IN, USA) using commercial reagents. Up to four blood pressure measurements were obtained from each participant. We used the average of the last two measurements for participants who had three or four measurements, the second one for participants with only two measurements, and the only one for participants who had one measurement to establish hypertension status. Waist circumference was measured at the high point of the iliac crest at minimal respiration to the nearest 0·1 cm at the end of normal expiration. Using three questions about the monthly frequency of beer, wine and hard liquor consumption, we summed the three frequencies and created the following categories for alcohol use: 0, , 1, 1 -2, and . 2 times per month. We created three categories (none, , 150, and $ 150 min/week) of leisure-time physical activity by summing the minutes engaged in a series of moderate and vigorous activities. The amount of time spent watching television or videos or using a computer was derived from the question 'Over the past 30 days, on a typical day how much time altogether did you spend sitting and watching TV or videos or using a computer outside of work?'. The question 'Have you used or taken any vitamin, minerals, or other dietary supplements in the past month?' was used to establish the use of such supplements.
We limited the analytic sample to participants who were examined in the morning because reference measurements for concentrations of glucose and triacylglycerols were collected only for these persons. We excluded participants aged , 20 years, those who had fasted , 8 h and pregnant women. In addition, we excluded participants with selfreported diabetes because medical treatments and lifestyle changes might have led to changes in concentrations of the tocopherols and other measures. We calculated Pearson correlation coefficients using the sampling weights in SAS (SAS Institute Inc. Cary, NC, USA). In addition, we examined the associations between the tocopherols and concentrations of glucose, glycosylated haemoglobin, insulin and C-peptide by using multiple linear regression analyses. We ran correlation and regression analyses with untransformed and log-transformed dependent and independent variables. To account for the complex sampling design of the survey, we conducted regression analyses by using the software SUDAAN (Research Triangle Institute, Research Triangle Park, NC, USA).
Results
A total of 2188 participants aged $ 20 years attended the morning session of the mobile examination centre. Of these 1900 had fasted for $ 8 h. After excluding pregnant women and people with self-reported diabetes, 1667 participants remained. Additional exclusions for missing data for concentrations of a-tocopherol, g-tocopherol, glucose, glycosylated haemoglobin, insulin and C-peptide left 1368 participants in the sample. After excluding participants with missing data for the covariates, 1289 participants remained of whom 640 were men, 649 women, 639 white, 247 African American, 286 Mexican American, and 117 of other races or ethnicities.
Among the 1289 participants, a-tocopherol ranged from 9·66 to 131·39 mmol/l (mean 29·54 mmol/l; median 25·22 mmol/l; geometric mean 27·04 mmol/l) and g-tocopherol ranged from 0·18 to 45·82 mmol/l (mean 5·54 mmol/l; median 5·12 mmol/l; geometric mean 4·65 mmol/l). After adjusting for concentrations of total cholesterol and triacylglycerols, the correlation coefficient between untransformed concentrations of the tocopherols was 2 0·58 and that for log-transformed concentrations 2 0·64.
Correlation coefficients adjusted for age and concentrations of total cholesterol and triacylglycerols between aand g-tocopherol and concentrations of glucose, glycosylated haemoglobin, insulin and C-peptide are presented in Table 1 . a-Tocopherol concentration was inversely associated with glucose concentration, and g-tocopherol concentration was positively correlated with all four measures. The mean concentrations (adjusted for age and concentrations of total cholesterol and triacylglycerols) of glucose, glycosylated haemoglobin, insulin and C-peptide for quintiles of concentrations of aand g-tocopherol are shown in Table 2 . Significant inverse linear trends were found for adjusted mean concentrations of glucose, glycosylated haemoglobin, insulin and C-peptide by quintiles of a-tocopherol concentration. In contrast, adjusted mean concentrations of these four variables increased across quintiles of g-tocopherol concentration.
Among a subgroup of participants who did not report using or taking any vitamin, minerals or other dietary supplements in the past month, concentrations of a-tocopherol were not significantly associated with concentrations of glucose but were significantly and inversely associated with concentrations of C-peptide (Table 3 ). The associations of concentrations of g-tocopherol remained significantly associated with concentrations of glucose, glycosylated haemoglobin, insulin and C-peptide.
In linear regression analysis, the concentration of atocopherol was inversely associated with glucose concentration after adjustment for all covariates (Table 4 ). In con- .
* P for linear trend was calculated using the median concentrations of tocopherols for the quintiles using linear regression analysis. 
* P value derived from linear regression.
trast, g-tocopherol concentration was significantly and directly associated with concentrations of glucose and glycosylated haemoglobin. We examined also whether the associations differed by sex by including interaction terms between sex and the tocopherols. No interaction was detected (P$ 0·05). When we repeated the regression analyses after excluding participants who reported using vitamin, mineral or dietary supplements (Table 5 ), the concentration of a-tocopherol was inversely associated with the concentration of C-peptide, and the concentration of g-tocopherol continued to be positively and significantly associated with concentrations of glucose and glycosylated haemoglobin.
Discussion
Given the role that oxidative stress might play in the pathogenesis of diabetes and the hope that antioxidants might mitigate damage caused by oxidative stress, an understanding of the associations between various antioxidants and concentrations of glucose, glycosylated haemoglobin, insulin and C-peptide could help in understanding which antioxidants might reduce the risk of diabetes. We found that a-tocopherol was inversely associated with the concentration of glucose in the full analytic sample but not among participants who did not report using or taking any vitamin, mineral or other dietary supplements, and Table 3 . Adjusted mean concentrations of glucose, glycosylated haemoglobin, insulin and C-peptide by quintiles of concentrations of a-and g-tocopherol among 659 US adults aged $20 years after excluding participants who reported using vitamin, mineral or dietary supplements, adjusted for age and concentrations of total cholesterol and triacylglycerols using analysis of covariance; National Health and Nutrition Examination Survey 1999 (Mean values with their standard errors) a-Tocopherol quintiles (mmol/l)
* Adjusted for age, sex, race or ethnicity, education, smoking status, total cholesterol concentration, triacylglycerol concentration, systolic blood pressure, waist circumference, alcohol use, physical activity, watching television or videos, and vitamin/mineral/ dietary supplement use.
that g-tocopherol was positively associated with concentration of glucose and glycosylated haemoglobin. Free radicals are comprised of reactive oxygen species and reactive nitrogen species. Because of the differences in the chemical structures of aand g-tocopherol, the former is more likely to be effective against damage that reactive oxygen species could cause whereas g-tocopherol has the ability to trap reactive nitrogen oxide species (Jiang et al. 2001) . Whether reactive nitrogen oxide species play a role in the pathogenesis of diabetes is unknown, however.
A role for oxidative stress in the pathogenesis of diabetes has not been conclusively demonstrated, but several lines of evidence support the possibility (Ruhe & McDonald 2001; Evans et al. 2002) . Obesity, the major modifiable determinant of diabetes, is characterized by increased oxidative stress (Fenster et al. 2002; Keaney et al. 2003) , which, by disturbing endothelial function (Perticone et al. 2001) , may contribute to the development of diabetes (Duncan et al. 1999 ). Furthermore, elevated glucose concentrations increase oxidative stress through the production of mitochondrial reactive oxygen species, non-enzymatic glycation of proteins and glucose autooxidation (Evans et al. 2002) . Thus, once a persons's glucose concentration begins to rise before the onset of diabetes, oxidative stress may increase further.
Some indirect evidence suggests that g-tocopherol may play a role in the etiology of diabetes. g-Tocopherol exhibits anti-inflammatory activity by inhibiting COX-2 activity (Jiang et al. 2000) or other mechanisms (Jiang & Ames, 2003) and inflammation may be important in the pathogenesis of diabetes (Pickup & Crook, 1998) . Furthermore, g-tocopherol, but not a-tocopherol, may provide some protection to b-cells against the effects of interleukin-1b (Sjoholm et al. 2000) .
Thus, our finding of a positive association between the concentration of g-tocopherol and concentrations of glucose and glycosylated haemoglobin is perhaps surprising. To the degree that fasting insulin concentration represents insulin resistance, the lack of a significant association between g-tocopherol concentration and insulin concentration suggests that an increase in insulin resistance is not responsible for the positive association between concentrations of g-tocopherol and glucose. Whether g-tocopherol somehow interferes with the uptake of glucose by cells, promotes output of glucose by the liver, enhances glucose-counter-regulatory hormones or works through other mechanisms is unknown. Previously, a prospective study failed to find a significant association between g-tocopherol concentration and diabetes incidence (Mayer-Davis et al. 2002) , and a cross-sectional study did not find that plasma glucose concentration was significantly associated with g-tocopherol concentration (Ylonen et al. 2003) .
Vitamin E supplementation studies, dietary vitamin E studies and cross-sectional studies of circulating concentrations of vitamin E have produced inconsistent findings about the associations between vitamin E (mostly a-tocopherol) and concentrations of glucose, glycated proteins and insulin. In studies of people with diabetes, supplementation with vitamin E reduced glucose concentrations in some (Paolisso et al. 1993a,b; Gokkusu et al. 2001) but not other studies (Reaven et al. 1995; Fuller et al. 1996; Gomez-Perez et al. 1996; Upritchard et al. 2000) . In several studies of adults who did not have diabetes, supplementation with vitamin E did not affect glucose concentrations (Meydani et al. 1994 (Meydani et al. , 1998 Mustad et al. 2002) , although it did lower glucose concentrations in another study (Paolisso et al. 1994 ). In addition, supplementation with a cocktail of antioxidants, including vitamin E, did not lower glucose concentrations (Miller et al. 1997) . Dietary vitamin E intake was not significantly associated with insulinmediated glucose disposal among healthy volunteers (Facchini et al. 1996) . Among participants without diabetes, plasma a-tocopherol concentration was not significantly associated with glucose concentration (Ylonen et al. 2003) . Two of three prospective studies found an inverse association between plasma concentration of vitamin E and diabetes incidence (Salonen et al. 1995; Reunanen et al. 1998; Mayer-Davis et al. 2002) .
In studies of people with diabetes, supplementation with vitamin E reduced concentrations of glycosylated haemoglobin or other glycated proteins in some (Ceriello et al. 1991; Jain et al. 1996; Gokkusu et al. 2001) but not in other studies (Reaven et al. 1995; Fuller et al. 1996; Gomez-Perez et al. 1996; Skrha et al. 1999 ). In another Table 5 . Results from linear regression analyses of glucose, glycosylated haemoglobin, insulin and C-peptide on concentrations of a-and g-tocopherol concentrations among 659 US adults aged $20 years after excluding participants who reported using vitamin, mineral or dietary supplements; National Health and Nutrition Examination Survey 1999-2000 a-Tocopherol g-Tocopherol
* Adjusted for age, sex, race or ethnicity, education, smoking status, total cholesterol concentration, triacylglycerol concentration, systolic blood pressure, waist circumference, alcohol use, physical activity, and watching television or videos. study, plasma vitamin E concentration was inversely associated with glycosylated haemoglobin status (Boeing et al. 2000) .
In another study of supplementation with vitamin E, fasting and 2 h insulin concentrations were lower at the end of the study than the beginning (Paolisso et al. 1995) . Other studies have suggested vitamin E benefits insulin action but not insulin secretion (Paolisso et al. 1993a,b) . In contrast to previous studies (Decsi et al. 1996; Facchini et al. 2000) , we did not observe a significant association between a-tocopherol concentration and insulin concentration. Finally, intake of vitamin E was not significantly associated with insulin sensitivity in one study (Sanchez-Lugo et al. 1997) .
The cross-sectional design of our study is a limitation, and thus the results should be viewed as hypothesis generating; we hope they will stimulate research in this area. Because we limited our analysis to participants who attended a morning examination, the resulting reduction in sample size may have limited our ability to detect associations. In addition, plasma concentrations of these forms of vitamin E may not be the most relevant physiologic measures, as concentrations of g-tocopherol may be higher in tissues than plasma. However, plasma concentrations are commonly studied. Because dietary intake of aand g-tocopherol was not available, we were unable to assess the contribution of diet to the concentrations of the tocopherols and the association between dietary intake of the tocopherols and concentrations of glucose, glycosylated haemoglobin, insulin and C-peptide.
In conclusion, we found g-tocopherol was positively associated with concentrations of glucose and glycosylated haemoglobin among study participants free of diagnosed diabetes. Because little is known about the associations between the various forms of tocopherol and concentrations of glucose, glycosylated haemoglobin, insulin and C-peptide, additional study of these associations is encouraged.
